Liraglutide in Adolescents With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 3, 2022

Study Completion Date

August 3, 2023

Conditions

Type 1 Diabetes

Interventions

DRUG

Liraglutide

Liraglutide 0.6 mg

Trial Locations (1)

UBMD Pediatrics, Division of Pediatric Endocrinology, Buffalo

All Listed Sponsors

lead

University at Buffalo

OTHER

NCT02516657 - Liraglutide in Adolescents With Type 1 Diabetes | Biotech Hunter | Biotech Hunter